Cargando…
Molecular Heterogeneity in Localized Diffuse Large B-Cell Lymphoma
The clinical and molecular characteristics of localized diffuse large B-cell lymphoma (DLBCL) with single nodal (SN) or single extranodal (SE) involvement remain largely elusive in the rituximab era. The clinical data of 181 patients from a retrospective cohort and 108 patients from a phase 3 random...
Autores principales: | Qin, Wei, Fu, Di, Shi, Qing, Dong, Lei, Yi, Hongmei, Huang, Hengye, Jiang, Xufeng, Song, Qi, Liu, Zhenhua, Cheng, Shu, Huang, Jinyan, Wang, Li, Xu, Pengpeng, Zhao, Weili |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454464/ https://www.ncbi.nlm.nih.gov/pubmed/34557402 http://dx.doi.org/10.3389/fonc.2021.638757 |
Ejemplares similares
-
Comparison of Nasopharyngeal MR, (18) F-FDG PET/CT, and (18) F-FDG PET/MR for Local Detection of Natural Killer/T-Cell Lymphoma, Nasal Type
por: Guo, Rui, et al.
Publicado: (2020) -
Integrated Genomic and Transcriptomic Analyses of Diffuse Large B-Cell Lymphoma With Multiple Abnormal Immunologic Markers
por: Sheng, Lingshuang, et al.
Publicado: (2022) -
Oncogenic Mutations and Tumor Microenvironment Alterations of Older Patients With Diffuse Large B-Cell Lymphoma
por: Zhu, Yue, et al.
Publicado: (2022) -
The findings on the CEUS of diffuse large B cell lymphoma in abdomen: A case report and literature review
por: Zhang, Yu-Qing, et al.
Publicado: (2023) -
Consecutive Hypoalbuminemia Predicts Inferior Outcome in Patients With Diffuse Large B-Cell Lymphoma
por: Wei, Xiaolei, et al.
Publicado: (2021)